Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content (Q43025115)
Jump to navigation
Jump to search
scientific article published in February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content |
scientific article published in February 2010 |
Statements
1 reference
Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content (English)
1 reference
R Balasubramanian
1 reference
J Gerrard
1 reference
C Dalla Man
1 reference
M J Firbank
1 reference
A Lane
1 reference
P T English
1 reference
C Cobelli
1 reference
R Taylor
1 reference
1 February 2010
1 reference
1 reference
Identifiers
1 reference